Trastuzumab (Herceptin) is a humanized monoclonal antibody used in the treatment of HER2-positive cancers. Trastuzumab binds to domain IV of the extracellular domain of the HER2/neu receptor. Cells treated with Trastuzumab undergo cell cycle arrest duri
* VAT and and shipping costs not included. Errors and price changes excepted